Evidence map›Paper›PMID 21166928›Full record

Trial reportMicrocirculation (New York, N.Y. : 1994)2011

Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment.

Geraldine F Clough, Veline L'Esperance, Magdalena Turzyniecka, Lara Walter, Andrew J Chipperfield, John Gamble, Andrew J Krentz, Christopher D Byrne

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Microcirculation (New York, N.Y. : 1994), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT00666029. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00666029 phase2completed

Implications for Treatment of the Metabolic Syndrome

Ran2006Enrolled40Registered outcomes2Posted comparisons0ConditionsMetabolic SyndromeArmsAtorvastatin, Placebo
PMID 19208914PMID 19929989PMID 20339006other papers from this trial
Open the trial in the graph
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Atorvastatin reduces endotoxin-induced microvascular inflammation via NOSII.Naunyn-Schmiedeberg's archives of pharmacology · 2015
    Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Geraldine F CloughInstitute of Developmental Sciences, School of Medicine, University of Southampton, Southampton General Hospital (MP 887), Southampton, UK. g.f.clough@soton.ac.uk
Veline L'Esperance
Magdalena Turzyniecka
Lara Walter
Andrew J Chipperfield
John Gamble
Andrew J Krentz
Christopher D Byrne
University of Southampton · GBUniversity of Birmingham · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

objectiveTo test the hypothesis that: (i) functional microvascular dilator capacity is independently associated with insulin sensitivity and age in individuals with central adiposity at risk of cardiovascular disease (CVD); and (ii) functional microvascular dilator capacity is improved by high dose statin treatment.

methodsFunctional dilator capacity (measured as change in laser Doppler blood flux from baseline during post occlusive reactive hyperemia [peak flux%resting flux; PF%RF] and flowmotion (power spectral density [PSD] analysis)) were assessed in 40 people with central adiposity and one or more other CVD risk factors. Measurements were made at rest and during acute hyperinsulinaemia before and six months after high dose atorvastatin (40 mg daily) or placebo.

resultsInsulin-induced change in PF%RF was independently associated with insulin sensitivity (M/I) (r = 0.46 p = 0.02) and age (r = -0.46 p = 0.02), which together explained almost half of the variance in PF%RF (adjusted r² = 0.37, p = 0.008). Whilst atorvastatin decreased LDL cholesterol by 51% (p < 0.001), PF%RF and flowmotion remained unchanged.

conclusionsInsulin sensitivity and age are independently associated with an insulin-induced change in functional microvascular dilator capacity in individuals with central adiposity at risk of CVD. Dilator capacity is not improved by six months high dose statin treatment.

Indexed as

HyperinsulinismInsulin ResistanceObesity, AbdominalAcute DiseaseAdultAgedAnticholesteremic AgentsAtorvastatinBlood Flow VelocityFemaleHeptanoic AcidsHumansHyperemiaMaleMicrocirculationMiddle AgedAnticholesteremic AgentsAtorvastatinHeptanoic AcidsPyrroles

Identifiers

PMID21166928
OpenAlexW1606911906

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.